Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurol Sci ; 26(5): 310-8, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16388364

RESUMO

Homocysteine increases in the acute phase of ischaemic stroke and from the acute to the convalescent phase, suggesting that hyper-homocysteinaemia may be a consequence rather than a causal factor. Therefore we measured homocysteine plasma levels in stroke patients in order to investigate possible correlations of homocysteine with stroke severity and clinical outcome. Further we looked for eventual differences in stroke subtypes. We prospectively studied plasma homocysteine levels in acute stroke patients admitted to the stroke unit of our department. Seven hundred and seventy-five ischaemic stroke patients, 39 cerebral haemorrhages and 421 healthy control subjects have been enrolled. Stroke severity and clinical outcome were measured with the Scandinavian Stroke Scale, the Rankin Scale and the Barthel Index. Stroke severity by linear stepwise regression analysis was not an independent determinant of plasma homocysteine levels. Homocysteine was not correlated with outcome measured by the Barthel Index. Mean plasma homocysteine of both ischaemic and haemorrhagic stroke was significantly higher than controls (p<0.05). Homocysteine had an adjusted odds ratios (OR) of 4.2 (95% CI 2.77-6.54) for ischaemic stroke and of 3.69 (95% CI 1.90-7.17) for haemorrhagic stroke. Compared with the lowest quartile, the upper quartile was associated with an adjusted OR of ischaemic stroke due to small artery disease of 17.4 (95% CI 6.8-44.3). Homocysteine in the acute phase of stroke was not associated with stroke severity or outcome. Elevated plasma homocysteine in the acute phase of stroke was associated with both ischaemic and haemorrhagic stroke. Higher levels are associated with higher risk of small artery disease subtype of stroke.


Assuntos
Doenças Arteriais Cerebrais/sangue , Homocisteína/sangue , Acidente Vascular Cerebral/sangue , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Análise de Regressão , Fatores de Risco , Índice de Gravidade de Doença , Acidente Vascular Cerebral/epidemiologia
2.
Neurology ; 63(8): 1500-2, 2004 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-15505175

RESUMO

The authors analyzed the CLCN2 chloride channel gene in 112 probands with familial epilepsy, detecting 18 common polymorphisms. Two brothers with generalized epilepsy and their asymptomatic father, and a father and son with focal epilepsy carried variants of possible functional significance that were not found in 192 controls. The authors conclude that CLCN2 mutations may be a rare cause of familial epilepsy. Further studies are needed to test if polymorphisms in this gene are associated with epilepsy.


Assuntos
Encéfalo/metabolismo , Canais de Cloreto/genética , Epilepsia/genética , Predisposição Genética para Doença/genética , Mutação/genética , Polimorfismo Genético/genética , Adulto , Idade de Início , Processamento Alternativo/genética , Encéfalo/fisiopatologia , Canais de Cloro CLC-2 , Criança , Canais de Cloreto/biossíntese , Análise Mutacional de DNA , Eletroencefalografia , Epilepsia/congênito , Epilepsia/fisiopatologia , Etnicidade/genética , Feminino , Testes Genéticos , Humanos , Masculino , Pessoa de Meia-Idade , Inibição Neural/genética , Linhagem , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores de GABA/genética , Receptores de GABA/metabolismo , Convulsões/genética , Transmissão Sináptica/genética
3.
Neurology ; 51(2): 493-8, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9710024

RESUMO

OBJECTIVE: To map the gene causing an unusual EEG pattern of delta bursts that appears to segregate as an autosomal dominant trait in an Italian family. The EEG pattern was observed in four family members affected by idiopathic generalized epilepsy (IGE) and in six other clinically unaffected members. METHODS: All available family members underwent clinical and EEG examination. DNA samples were obtained and used to perform a whole-genome scan with 270 microsatellite markers. After the first linked marker was identified, 12 additional markers in the same chromosomal region were tested to confirm linkage and define a candidate interval. RESULTS: The gene responsible for the EEG trait was mapped to an 11-cM interval on the proximal short arm of chromosome 3 (3p14.2-p12.1). CONCLUSION: In this family, a characteristic EEG activity is due to the effect of a single gene on chromosome 3p. A gene encoding a Ca2+ channel subunit maps in the interval and is a potential candidate for the trait. The clinical expression of epilepsy in four family members may reflect the interaction of additional genes, though environmental or other factors cannot be excluded.


Assuntos
Cromossomos Humanos Par 3 , Eletroencefalografia , Epilepsia Generalizada/fisiopatologia , Genes Dominantes , Ligação Genética , Mapeamento Cromossômico , Epilepsia Generalizada/genética , Genótipo , Humanos , Linhagem
4.
Epilepsy Res ; 10(2-3): 166-73, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1817956

RESUMO

Both interictal and ictal EEG phenomena are commonly activated by functional instability. The different non-REM sleep stages comprise long-lasting periods of cyclic alternating pattern (CAP) in which arousal fluctuates between 'A phases' of greater arousal and 'B phases' of less arousal, and periods in which vigilance maintains a tonic stability (non-CAP). Previous studies have revealed that phase A induces a marked enhancement of generalized EEG paroxysms, a minor though significant activation of focal lesional bursts, but no effect on rolandic functional spikes. Conversely, phase B exerts an inhibitory modulation, especially on bilateral interictal phenomena. Because of the opposite influence of phase A and phase B also on muscle tone, we assessed the amount and distribution of nocturnal partial motor seizures in 6 subjects affected by focal epilepsy. The polysomnograms included 45 motor seizures, 43 of which occurred during non-REM sleep. Nocturnal fits were significantly more frequent in stages 1 and 3 (P less than 0.0001). Among the non-REM seizures, 42 appeared in CAP (P less than 0.0001) and always in phase A. The transient arousal and the concomitant muscle tone activation expressed by phase A of CAP is likely to support the motor components of nocturnal seizures. Sleep analysis in terms of CAP and non-CAP provides a better understanding of the continuum from subclinical EEG paroxysms to clinical manifestations and of the relations between vigilance and seizure disorders.


Assuntos
Epilepsias Parciais/fisiopatologia , Fases do Sono/fisiologia , Adolescente , Adulto , Eletroencefalografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Movimento/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...